Real-World Breast Cancer Patient Follow-Up Practices by Medical Oncologists in India—A Survey Report

 

 Permissions and Reprints

Abstract

Background In India, breast cancer patients' post-treatment follow-up practices are not known. We did this survey to understand how the breast cancer patients are followed-up and tried to explore the challenges associated with it.

Methods We conducted a survey-based study among Indian oncologists. Seven questions were framed pertaining to follow-up practices. Answers were provided in the form of multiple options. Google forms platform was used. Survey was circulated through social media apps and through mail. We sought suggestions and opinions to address the challenges from participants.

Results A total of 158 medical oncologists responded to this survey. 10% were not aware that only history and clinical examination are the scientific recommendations for follow-up. Ninety percent of the medical oncologists felt clinical breast examination as an uncomfortable practice for patients and physicians and 39% ordered a chest X-ray and an ultrasound abdomen. Annual mammogram was ordered by 83%, and blood investigations were recommended by 14% routinely. The majority (49.6%) felt that the absence of a female attendant, physician and patient factors were responsible for nonadherence to clinical breast examination. The DEXA scan was recommended by 84 (53%) medical oncologists regularly for patients on aromatase inhibitors, while 23 (14%) did not recommend it.

Conclusion There is a disparity between scientific recommendations and real-world follow-up practices. A large number of medical oncologists relied on chest X-ray and ultrasound abdomen. There is an unmet need to address this issue.

Publication History

Article published online:
05 February 2022

© 2022. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

• References

• 1 Doval DC, Radhakrishna S, Tripathi R. et al. A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery. Sci Rep 2020; 10 (01) 5886
  CrossrefPubMedGoogle Scholar
• 2 Lurie RH, Anderson BO, Abraham J. et al. NCCN Guidelines Version 6.2020. Breast Cancer 2020
  PubMedGoogle Scholar
• 3 Cardoso F, Kyriakides S, Ohno S. et al; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol 2019; 30 (08) 1194-1220
  CrossrefPubMedGoogle Scholar
• 4 Khatcheressian JL, Hurley P, Bantug E. et al; American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31 (07) 961-965
  CrossrefPubMedGoogle Scholar
• 5 Henry NL, Hayes DF, Ramsey SD, Hortobagyi GN, Barlow WE, Gralow JR. Promoting quality and evidence-based care in early-stage breast cancer follow-up. J Natl Cancer Inst 2014; 106 (04) dju034-dju034
  CrossrefPubMedGoogle Scholar
• 6 Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 1994; 271 (20) 1593-1597
  CrossrefPubMedGoogle Scholar
• 7 Palli D, Russo A, Saieva C. et al; National Research Council Project on Breast Cancer Follow-up. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. JAMA 1999; 281 (17) 1586
  CrossrefPubMedGoogle Scholar
• 8 Ghezzi P, Magnanini S, Rinaldini M. et al; The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994; 271 (20) 1587-1592
  CrossrefPubMedGoogle Scholar
• 9 Welt A, Bogner S, Arendt M. et al. Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center. J Cancer Res Clin Oncol 2020; 146 (06) 1559-1566
  CrossrefPubMedGoogle Scholar
• 10 Niño de Guzmán E, Song Y, Alonso-Coello P. et al. Healthcare providers' adherence to breast cancer guidelines in Europe: a systematic literature review. Breast Cancer Res Treat 2020; 181 (03) 499-518
  CrossrefPubMedGoogle Scholar
• 11 Foster JA, Abdolrasulnia M, Doroodchi H, McClure J, Casebeer L. Practice patterns and guideline adherence of medical oncologists in managing patients with early breast cancer. J Natl Compr Canc Netw 2009; 7 (07) 697-706
  CrossrefPubMedGoogle Scholar
• 12 Zaluska-Kusz J, Litwiniuk M. 194P follow up after breast cancer in real life. Ann Oncol 2020; 31: S86
  CrossrefGoogle Scholar
• 13 Feddock CA. The lost art of clinical skills. American Journal of Medicine 2007; 120: 374-8
  CrossrefPubMedGoogle Scholar
• 14 Bryan T, Snyder E. The clinical breast exam: a skill that should not be abandoned. J Gen Intern Med 2013; 28 (05) 719-722
  CrossrefPubMedGoogle Scholar
• 15 Shapiro CL, Van Poznak C, Lacchetti C. et al. Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline. J Clin Oncol 2019; 37 (31) 2916-2946
  CrossrefPubMedGoogle Scholar
• 16 Hayes DF. Further progress for patients with breast cancer. N Engl J Med 2019; 380 (07) 676-677
  CrossrefPubMedGoogle Scholar